U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H28FN5O2.C7H8O3S
Molecular Weight 537.647
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BESIGLIPTIN TOSYLATE

SMILES

CC1=CC=C(C=C1)S(O)(=O)=O.[H][C@@]23CN(C[C@]2([H])C[C@](C)(C3)NCC(=O)N4C[C@@H](F)C[C@H]4C#N)C(=O)N(C)C

InChI

InChIKey=VBMNNLBIPDGFBS-XGXURLCGSA-N
InChI=1S/C18H28FN5O2.C7H8O3S/c1-18(21-8-16(25)24-11-14(19)4-15(24)7-20)5-12-9-23(10-13(12)6-18)17(26)22(2)3;1-6-2-4-7(5-3-6)11(8,9)10/h12-15,21H,4-6,8-11H2,1-3H3;2-5H,1H3,(H,8,9,10)/t12-,13+,14-,15-,18+;/m0./s1

HIDE SMILES / InChI
Jiangsu HengRui Medicine Co. is developing SHR-117887, an orally active dipeptidyl peptidase-4 (CD26 antigen) inhibitor for the treatment of type 2 diabetes. SHR-117887 is a potent DPP-4 inhibitor that improves metabolic control and β-cell function in diabetic rodent models. SHR-117887 is in phase II clinical trials for the treatment of type 2 diabetes.

Approval Year

PubMed

PubMed

TitleDatePubMed
Acute and chronic administration of SHR117887, a novel and specific dipeptidyl peptidase-4 inhibitor, improves metabolic control in diabetic rodent models.
2012 Aug
Hydrolytic Metabolism of Cyanopyrrolidine DPP-4 Inhibitors Mediated by Dipeptidyl Peptidases.
2019 Mar

Sample Use Guides

Type 2 Diabetes: Experimental: SHR-117887 (50mg q.d)/Metformin Patients are administered oral placebo once daily and metformin 500mg TID for 4 weeks at the run-in period. After randomised,patients adminitered SHR117887 50mg QD and metformin 500mg TID for 12 weeks. Experimental: SHR-117887 (100mg q.d)/Metformin patients are administered oral placebo once daily and metformin 500mg TID for 4 weeks at the run-in period.After randomised, patients adminitered SHR-117887 100mg QD and metformin 500mg TID for 12 weeks.
Route of Administration: Oral
Name Type Language
BESIGLIPTIN TOSYLATE
Common Name English
SHR-117887
Common Name English
(3AS,6AR)-5-((2-((2S,4S)-2-CYANO-4-FLUORO-PYRROLIDIN-1-YL)-2-OXO-ETHYL)AMINO)-N,N,5-TRIMETHYL-1,3,3A,4,6,6A-HEXAHYDROCYCLOPENTA(C)PYRROLE-2-CARBOXAMIDE; 4-METHYLBENZENESULFONIC ACID
Systematic Name English
CYCLOPENTA(C)PYRROLE-2(1H)-CARBOXAMIDE, 5-((2-((2S,4S)-2-CYANO-4-FLUORO-1-PYRROLIDINYL)-2-OXOETHYL)AMINO)HEXAHYDRO-N,N,5-TRIMETHYL-, (3A.ALPHA.,5.ALPHA.,6A.ALPHA.)-, 4-METHYLBENZENESULFONATE (1:1)
Systematic Name English
SHR117887
Code English
Code System Code Type Description
FDA UNII
06SMN21EQE
Created by admin on Sat Dec 16 11:52:17 GMT 2023 , Edited by admin on Sat Dec 16 11:52:17 GMT 2023
PRIMARY
CAS
1177460-72-8
Created by admin on Sat Dec 16 11:52:17 GMT 2023 , Edited by admin on Sat Dec 16 11:52:17 GMT 2023
PRIMARY
PUBCHEM
91667592
Created by admin on Sat Dec 16 11:52:17 GMT 2023 , Edited by admin on Sat Dec 16 11:52:17 GMT 2023
PRIMARY